Therapeutic Protocol for Alopecia

The 2018 document outlines the pathogenesis and treatment options for androgenic alopecia (AA). It confirms that minoxidil and finasteride are the only two FDA-approved treatments for AA, with low-frequency laser therapy also recognized by the FDA. It mentions other treatments such as platelet-rich plasma, oral contraceptives, anti-androgens, and vitamin complexes with amino acids, which may improve hair thickness but lack strong evidence of effectiveness. The document notes the increasing popularity of low-frequency laser therapy and the promising results of plasma-rich platelets, despite the absence of a standardized protocol. It also highlights advancements in hair transplant techniques that offer natural and definitive results, and the potential future of hair follicle multiplication. The conclusion emphasizes that while medical treatments can prevent progression and thinning of hair follicles, they do not always enable hair recovery.